Hydrocodone Bitartrate and Ibuprofen

Product NDC
0603-3584
Requested package NDC
0603-3584-21
11-digit product format
006033584
Labeler code
0603
Product ID
0603-3584_5a16489b-5f9c-4961-8b6f-4fa15ebf7396
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
hydrocodone bitartrate and ibuprofen
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Par Pharmaceutical
Application
ANDA077727
Marketing category
ANDA
Marketing start
2006-11-06
Marketing end
0000-00-00
Substance
HYDROCODONE BITARTRATE; IBUPROFEN
Active strength
5 mg/1; mg/1
Pharmacologic classes
Opioid Agonist [EPC],Opioid Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
DEA schedule
CII
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0603-35840603-3584-21DDiscontinued by firm2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2019-12-13 00:20 UTC2019-12A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-0674a2ff9319b5…
2021-12-28 21:50 UTC2021-12A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-06782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-0687673890dc5c…
2021-03-12 10:30 UTC2021-03A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-065aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-068869cabd3fbd…
2020-11-12 02:37 UTC2020-11A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-06c0c555d07b60…
2019-12-14 00:12 UTC2019-12A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-063f01610625f2…
2019-09-15 20:21 UTC2019-09A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-06b00525d2431f…
2019-07-19 19:46 UTC2019-07A077727-001HYDROCODONE BITARTRATE AND IBUPROFEN5MG;200MGTABLET / ORALAB2006-11-06ea99ee380514…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A077727-001AB174a2ff9319b5…
2021-12-28 21:50 UTC2021-12A077727-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A077727-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A077727-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A077727-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A077727-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A077727-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A077727-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A077727-001AB1ea99ee380514…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0603-3584-21EA - Each0603-3584d9f5d205-f929-417e-85a1-45a7b02e4f1312015-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYDROCODONE BITARTRATEACTIVE INGREDIENTNO70W886KKHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
IBUPROFENACTIVE INGREDIENTWK2XYI10QMHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
HYDROCODONEACTIVE MOIETY6YKS4Y3WQ7HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
IBUPROFENACTIVE MOIETYWK2XYI10QMHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
D&C RED NO. 27INACTIVE INGREDIENT2LRS185U6KHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
POVIDONESINACTIVE INGREDIENTFZ989GH94EHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPHYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0603-3584-2100603358421100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-3584-21) 2006-11-060000-00-00NoNoCurrent